| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 07/31/2003 | WO2002020500A3 Materials and methods to potentiate cancer treatment |
| 07/31/2003 | US20030144521 Hydrogenation of a corresponding nonracemic 1-(4-benzoxy phenyl)-2-(4-hydroxy-4- phenyl-piperidin-1-yl)-1-propanone using a catalyst system comprising ruthenium, a nonracemic diphosphine ligand, a bidentate amine ligand selected from |
| 07/31/2003 | US20030144519 Process for preparing a piperidine derivative |
| 07/31/2003 | US20030144328 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/31/2003 | US20030144326 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 07/31/2003 | US20030144323 Phenylalkynes |
| 07/31/2003 | US20030144322 Analogs of cocaine |
| 07/31/2003 | US20030144319 2-Substituted piperidine analogs as excitatory amino acid receptor antagonists that block N-methyl-D-aspartic acid receptors; neuroprotective agents; stroke; brain disorders; antiischemic agents; anxiolytic agents; headaches; analgesics |
| 07/31/2003 | US20030144291 Substituted indan derivatives |
| 07/31/2003 | US20030144289 Dopamine and serotonin reuptake antagonists, used for the prophylaxis of drug abuse or dependence, neurodegenerative diseases or as antidepressants |
| 07/31/2003 | US20030144285 Cholinergic agents such as 4-Butyl-1-(4-phenyl-4-oxo-1-butyl) piperidine, administered as cognition activators and for prophylaxis of vision defects |
| 07/31/2003 | US20030144273 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity |
| 07/31/2003 | US20030144270 Neurokinin receptor antagonists comprising heterocyclic amides used as antiemetics, antidepressants and/or antitussive agents |
| 07/31/2003 | US20030144267 Novel compounds |
| 07/31/2003 | US20030143481 Image forming material and ammonium compound |
| 07/31/2003 | US20030140431 3-(2,5-Diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 07/31/2003 | CA2473036A1 Melanocortin receptor agonists |
| 07/31/2003 | CA2471389A1 Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1yl)-1-propanol compounds |
| 07/30/2003 | EP1330464A2 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation |
| 07/30/2003 | EP1330437A1 Oligomeric hindered amine light stabilizers based on multi-functional carbonyl compounds and methods of making same |
| 07/30/2003 | EP1330436A1 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr3-3 receptor antagonists |
| 07/30/2003 | EP1330248A2 New treatments for restless legs syndrome |
| 07/30/2003 | EP1252141B1 Tosylproline analogs as thymidylate synthase inhibitors |
| 07/30/2003 | CN1433411A Chemical compounds |
| 07/30/2003 | CN1433402A Cycloamine CCR5 receptor antagonists |
| 07/29/2003 | US6600047 Substantially free from amlodipine aspartate side products, by reacting amlodipine or an acid addition salt thereof with excess maleic acid under acidic environment |
| 07/29/2003 | US6599963 Polymer substrate, and a synergistic mixture of a hindered amine and a phosphorus or bromine compound. |
| 07/29/2003 | US6599922 Antiarrhythmia agents |
| 07/29/2003 | US6599919 Administering reversible competitive inhibitor of enzyme in an amount effective to enhance activity of enzyme in cell |
| 07/29/2003 | US6599904 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
| 07/29/2003 | US6599890 Inhibitors of matrix metalloproteinases or the production of tumor necrosis factor |
| 07/29/2003 | US6599861 Herbicides |
| 07/29/2003 | CA2188690C Selective thrombin inhibitors |
| 07/24/2003 | WO2003059883A1 (4-oxopiperidin-1-yl)benzoic acid derivatives and process for their preparation |
| 07/24/2003 | WO2003059882A1 Phenoxy piperidines for treating diseases such as schizophrenia and depression |
| 07/24/2003 | WO2003059335A1 Phenyl sulfoxides and phenyl sulfones |
| 07/24/2003 | WO2003059265A2 Compositions and methods for treating heart failure |
| 07/24/2003 | WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction |
| 07/24/2003 | WO2003031411A3 Direct resolution of racemic threo-methylphenidate hydrochloride |
| 07/24/2003 | US20030139599 Method for the production of esters of unsaturated carboxylic acids |
| 07/24/2003 | US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 07/24/2003 | US20030139455 Amlodipine salt forms and processes for preparing them |
| 07/24/2003 | US20030139449 Anxiolytic agents; psychological disorders; cognition activators |
| 07/24/2003 | US20030139448 Antidiarrhea agents; gastrointestinal disorders |
| 07/24/2003 | US20030139447 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 07/24/2003 | US20030139443 Anxiolytic agents; veterinary medicine |
| 07/24/2003 | US20030139423 Central nervous system disorders; psychological disorders |
| 07/24/2003 | US20030139419 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 07/24/2003 | US20030139414 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 07/24/2003 | US20030139408 Analgesics; cognition activators |
| 07/24/2003 | US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 07/24/2003 | US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders |
| 07/24/2003 | US20030139348 Animal growth regulators |
| 07/24/2003 | CA2473374A1 Phenyl sulfoxides and phenyl sulfones |
| 07/23/2003 | EP1328516A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds |
| 07/23/2003 | EP1328514A1 Amide derivatives as nmda receptor antagonists |
| 07/23/2003 | EP1328512A2 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists |
| 07/23/2003 | EP0788480B1 Crystallisation of levobupivacaine and analogues thereof |
| 07/23/2003 | CN1432012A Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 07/23/2003 | CN1432009A Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 07/22/2003 | US6596874 Salt formation by reaction using benzenesulfonic acid |
| 07/22/2003 | US6596754 Preventives/remedies for multiple organ failure |
| 07/22/2003 | US6596741 Compounds of formula I exhibit activity as serotonin, norepinephrine, and dopamine reuptake inhibitors and can be used in the treatment of central nervous system and other disorders. |
| 07/22/2003 | US6596724 Oxadiazole and thiadiazole derivatives of dihydropyridine NPY antagonists |
| 07/22/2003 | US6596716 2-propane-sulphonamide derivatives |
| 07/22/2003 | CA2228572C Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy |
| 07/17/2003 | WO2003057874A1 Disease markers for renal diseaes and utilization thereof |
| 07/17/2003 | WO2003057671A1 Biaryl compound and use thereof |
| 07/17/2003 | WO2003057668A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 07/17/2003 | WO2003057254A1 Preventives/remedies for urinary disturbance |
| 07/17/2003 | WO2002055496A8 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression |
| 07/17/2003 | WO2002055495A8 Aryl piperidine derivatives as inducers of ldl-receptor expression |
| 07/17/2003 | US20030135063 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor |
| 07/17/2003 | US20030135045 Glycoprotein IIb/IIIa antagonists |
| 07/17/2003 | US20030134875 Production of agglomerates |
| 07/17/2003 | US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus |
| 07/17/2003 | US20030134840 Novel compounds |
| 07/17/2003 | US20030134827 Lactams or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic amide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors. |
| 07/17/2003 | CA2471760A1 Preventives/remedies for urinary disturbance |
| 07/16/2003 | EP1326841A1 Pyridinone derivatives for treatment of atherosclerosis |
| 07/16/2003 | EP1326840A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/16/2003 | EP1326834A2 2-substituted heterocyclic compounds |
| 07/16/2003 | EP1326833A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/16/2003 | EP1326832A1 Chemical compounds |
| 07/16/2003 | EP1326824A1 Pharmaceutical compounds |
| 07/16/2003 | EP1017385B1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
| 07/16/2003 | CN1430617A Process for producing carbostyril derivative |
| 07/16/2003 | CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1430605A Process for synthesis of amine ethers from secondary amino oxides |
| 07/16/2003 | CN1114592C Crystalline forms of osanetant |
| 07/16/2003 | CN1114591C Cyclic amide compounds |
| 07/16/2003 | CN1114406C Use of (+)-ÔÇÿalphaÔÇÖ-(2,3-dimethyoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol in treating mental depression disorders and bipolar psychonosema disorders |
| 07/15/2003 | US6593486 Reacting halobenzoic acid with 2,2,2-trifluoroethanol; thenhaloacetonitrile |
| 07/15/2003 | US6593474 Adrenergic blocking agents |
| 07/15/2003 | US6593351 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 07/15/2003 | US6593348 Opiate compounds, methods of making and methods of use |
| 07/15/2003 | US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 07/15/2003 | US6593346 Substituted 3-(piperidin-1-ylmethyl)cyclopentylamines, useful as modulators of the chemokine receptors CCR-5 and/or CC R-3. |